87 related articles for article (PubMed ID: 12568311)
1. Sequence dependence of C5-propynyl-dU,dC-phosphorothioate oligonucleotide inhibition of the human IGF-I receptor: mRNA, protein, and cell growth.
Fogarty RD; McKean SC; White PJ; Atley LM; Werther GA; Wraight CJ
Antisense Nucleic Acid Drug Dev; 2002 Dec; 12(6):369-77. PubMed ID: 12568311
[TBL] [Abstract][Full Text] [Related]
2. Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides.
Wraight CJ; White PJ; McKean SC; Fogarty RD; Venables DJ; Liepe IJ; Edmondson SR; Werther GA
Nat Biotechnol; 2000 May; 18(5):521-6. PubMed ID: 10802619
[TBL] [Abstract][Full Text] [Related]
3. Antisense inhibition of IGF receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytes.
White PJ; Fogarty RD; Werther GA; Wraight CJ
Antisense Nucleic Acid Drug Dev; 2000 Jun; 10(3):195-203. PubMed ID: 10905556
[TBL] [Abstract][Full Text] [Related]
4. Regulation of vascular smooth muscle cell insulin-like growth factor I receptors by phosphorothioate oligonucleotides. Effects on cell growth and evidence that sense targeting at the ATG site increases receptor expression.
Delafontaine P; Meng XP; Ku L; Du J
J Biol Chem; 1995 Jun; 270(24):14383-8. PubMed ID: 7782298
[TBL] [Abstract][Full Text] [Related]
5. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells.
Müller M; Dietel M; Turzynski A; Wiechen K
Int J Cancer; 1998 Aug; 77(4):567-71. PubMed ID: 9679760
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.
Lee CT; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik IF; Carbone DP
Cancer Res; 1996 Jul; 56(13):3038-41. PubMed ID: 8674059
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.
Furukawa J; Wraight CJ; Freier SM; Peralta E; Atley LM; Monia BP; Gleave ME; Cox ME
Prostate; 2010 Feb; 70(2):206-18. PubMed ID: 19790231
[TBL] [Abstract][Full Text] [Related]
9. Growth enhancement of normal human keratinocytes by the antisense oligonucleotide of retinoblastoma susceptibility gene.
Koike M; Ishino K; Ikuta T; Huh N; Kuroki T
Oncogene; 1995 Jan; 10(1):117-22. PubMed ID: 7824264
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
[TBL] [Abstract][Full Text] [Related]
11. [Combinational effects of K-ras and IGF-IR antisense oligodeoxynucleotide on proliferation and apoptosis of human pancreatic cancer Patu8988 cells].
Shen YM; Yang XC; Zhang MH; Shen JK; Sun YH
Ai Zheng; 2008 May; 27(5):496-504. PubMed ID: 18479599
[TBL] [Abstract][Full Text] [Related]
12. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
Chavany C; Connell Y; Neckers L
Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor.
Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ
J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143
[TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
Smetsers TF; van de Locht LT; Pennings AH; Wessels HM; de Witte TM; Mensink EJ
Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006
[TBL] [Abstract][Full Text] [Related]
15. A cytosine analog that confers enhanced potency to antisense oligonucleotides.
Flanagan WM; Wolf JJ; Olson P; Grant D; Lin KY; Wagner RW; Matteucci MD
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3513-8. PubMed ID: 10097067
[TBL] [Abstract][Full Text] [Related]
16. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
Gao WY; Han FS; Storm C; Egan W; Cheng YC
Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo.
Edmondson SR; Thumiger SP; Kaur P; Loh B; Koelmeyer R; Li A; Silha JV; Murphy LJ; Wraight CJ; Werther GA
Br J Dermatol; 2005 Feb; 152(2):225-30. PubMed ID: 15727632
[TBL] [Abstract][Full Text] [Related]
18. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of IGF-IR by Antisense Oligodeoxynucleotide auguments the sensitivity of bladder cancer cells to mitomycin.
Sun HZ; Wu SF; Tu ZH
Acta Pharmacol Sin; 2001 Sep; 22(9):841-6. PubMed ID: 11749868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
